Passage BIO, Inc.·4

May 19, 7:04 PM ET

Fotopoulos Alexandros 4

4 · Passage BIO, Inc. · Filed May 19, 2021

Insider Transaction Report

Form 4
Period: 2021-05-17
Fotopoulos Alexandros
Chief Technical Officer
Transactions
  • Award

    Restricted Stock Unit (RSU)

    2021-05-17+50,00050,000 total
    Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]1/4 of the RSUs will vest on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION